Innovation

f or pr event i on, heal i ng and t he cur e

2013 annual report and overview
2
Medical
Advisory
Board
Hwyda Arafat, Ph.D.
Professor
Department of Biomedical
Sciences
University of New England
Donald W. Bowden, Ph.D.
Professor of Biochemistry
and Internal Medicine.
Director, Center for Diabetes
Research. Associate Director,
Center for Human Genomics.
Wake Forest University School
of Medicine
Staley A. Brod, M.D.
Professor of Neurology
University of Texas, Houston
Tom L. Broderick, Ph.D.
Professor of Physiology
Division of Basic Sciences
Midwestern University
Gregory Brower, D.V.M., Ph.D.
Centenary Associate Professor
Cell and Developmental
Biology and Anatomy
School of Medicine
University of South Carolina
Ben Gerber, M.D., M.P.H.
Associate Professor of Medicine
Institute for Health Research
and Policy
University of Illinois at Chicago
Ira D. Goldne, M.D.
Professor of Medicine,
Endocrinology/Metabolism
University of California,
San Francisco
Michael Haller, M.D.
Assistant Professor,
Pediatric Endocrinology
University of Florida
Bethany Hall-Long, Ph.D., RNC
Professor,
Department of Nursing
University of Delaware
E. Carolyn Johnson, Ph.D, FACSM
Associate Professor and Non-
Clinical Internship Coordinator
Nutrition and Exercise Physiology,
College of Pharmacy
Washington State University
Spokane
William Jubiz, M.D.
Director Centro de
Endocrinology Metabolismo
y Diabetes Cali, Columbia
Robert L. Judd, Ph.D.
Chair, Boshell Diabetes and
Metabolic Diseases Research
Program Auburn University
Steven Koevary, Ph.D.
Professor/Chairman
Department of Biomedical
Sciences and Disease
New England College
of Optometry
Suzanne Laychock, Ph.D.
Professor of Pharmacology
and Toxicology and Senior
Associate Dean for Research
and Biomedical Education
The University of Buffalo
School of Medicine and
Biomedical Sciences
Lucy D. Mastrandea, MD, Ph.D.
Assistant Professor
Division of Pediatric
Endocrinology
Womens and Childrens
Hospital of Buffalo
Marcia McInerney, Ph.D.
Distinguished University
Professor and Chair Medicinal
and Biological Chemistry
College of Pharmacy,
University of Toledo
Joshua Miller, Ph.D.
Associate Professor
Department of Medical Pathology
UC Davis Medical Center
Raghu G. Mirmira, M.D., Ph.D.
Eli Lilly Chair in Pediatric Diabetes
Associate Professor of Pediatrics,
Medicine, and Physiology
Indiana University School
of Medicine
Charles Mobbs, Ph.D.
Professor,
Neuroscience, Endocrinology,
and Geriatrics
Mt. Sinai School of Medicine
Svetlana Mojsov, Ph.D.
Research Associate Professor
Rockefeller University
Merrily Poth, M.D.
Professor, Retired
Pediatric Endocrinology and
Metabolism Uniformed Services
of the Health Sciences
Steven Sansom, Ph.D.
Associate Professor
Dept. of Physiology
and Biophysics University of
Nebraska Medical Center
Thomas Schermerhorn, VMD,
Dipl. ACVIM
Associate Professor, Small
Animal Internal Medicine
College of Veterinary Medicine
Kansas State University
Janet Silverstein, M.D.
Professor of Pediatrics
University of Florida College
of Medicine
Ya-Xiong Tao, Ph.D.
Associate Professor
Department of Anatomy,
Physiology, and Pharmacology
College of Veterinary Medicine
Auburn University
Roger Zoorob, MD, MPH
Professor and Chair,
Department of Family and
Community Medicine
Vanderbilt University
2013 will be remembered for the beginning of our nations role in
providing healthcare for millions of people who could not previously
afford insurance or who were denied insurance because of
pre-existing medical problems such as diabetes. Although politicians
may disagree on how to improve our health care system, I
doubt that anyone believes that a person living in the U.S.
should have to go bankrupt or die because of a lack of
insurance, or that insurance companies should be
able to continue denying insurance for pre-existing
conditions. Hopefully, in the future, the political
squabbling will lessen and the Affordable Care Act
will meet its goal of increasing preventive care that
could save billions of dollars by treating people, such
as the 79 million Americans with pre-diabetes, before
their medical costs escalate.
This year will also be remembered for the government
shutdown and budget sequester cuts. These cuts have made it
more critical than ever for organizations such as Diabetes Action
to help fund researchers who nd it more difcult to obtain NIH
funding. As one of the researchers we are funding wrote me, I
have to say if federal funding doesnt improve drastically many of us,
myself included, are seriously considering leaving researchIts just
not sustainable even with the best research ideas.Keep doing the
good work at DAREF, it is making a difference.
Despite these cuts in NIH funding, our ability to help some
researchers obtain long-term government funding was successful.
This year Dr. Nader Moniri at Mercer University let me know his
NIH grant was approved with the highest possible score of 10, and
said this wouldnt have been possible without the results collected
through our DAREF support.
We are excited to know that many of the projects we are supporting
can make a real difference in the lives of so many people with
diabetes. At Massachusetts General Hospital, Dr. Denise Faustman
is making progress on her goal to reverse type 1 diabetes with BCG
vaccine, and is beginning the second phase of this study. At Mt.
Sinai School of Medicine, Dr. Charles Mobbs has been able to show
that a ketogenic diet with healthy fats such as organic butter, olive
oil, coconut oil, and avocado oil can reverse the symptoms of both
diabetic neuropathy and nephropathy.
We are so thankful to all our donors who make it possible to fund
these groundbreaking studies, and a special thanks to our Diabetes
Action Team fundraisers and our volunteer Medical Advisory Board
and Board of Directors who are all so dedicated to improving the
lives of those with diabetes.
Pat DeVoe, RN, BSN, President
Presidents Message
Hopefully the
Affordable Care
Act will meet its
goal of increasing
preventive care
by treating millions
of Americans
with pre-diabetes
before their medical
costs escalate
2
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


Diabetes Action Research and Education Foundation is
committed to the prevention and treatment of diabetes and to
the funding of innovative, promising research aimed at finding
a cure for diabetes and diabetes related complications.

Alternative and complementary research

Grants for nutritional research

Promising research to nd a cure for diabetes

Innovative research to prevent and treat diabetes

International medical assistance

American Indian diabetes prevention

Childrens camp scholarship program

Education and prevention programs
Our Mission
Our Focus
Assurance that your money is used wisely
With a consistently low overhead and a small, dedicated staff, Diabetes Action strives to remain one of the
most efcient charities. Diabetes Action is especially proud to have received the highest ratings from the
following organizations:
CHARITY NAVIGATOR
Diabetes Action has received a rating of four out of a possible
four stars which, according to Charity Navigator, differentiates
Diabetes Action Research and Education from its peers and
demonstrates to the public it is worthy of their trust.


see charitynavigator.org
BETTER BUSINESS BUREAU WISE GIVING ALLIANCE
Diabetes Action has earned the right to display the Better
Business Bureau Wise Giving Alliance charity seal of
approval for meeting their comprehensive, in-depth
evaluation of Diabetes Actions governance, nances, fund
raising practices, solicitations, and informational materials.


see www.give.org
BEST IN AMERICA
The Independent Charities Seal of Excellence is awarded to
the members of Independent Charities of America and Local
Independent Charities of America that have, upon rigorous
independent review, been able to certify, document, and
demonstrate on an annual basis that they meet the highest
standards of public accountability, program effectiveness,
and cost effectiveness.
see www.independentcharities.org AMERICAN INSTITUTES OF PHILANTHROPY
Diabetes Action was one of the few diabetes organizations
to receive an A rating in 2013. AIP conducts an in-depth,
nancial analysis of audited nancial statements along
with a charitys tax forms and other reports so donors will
know how charitable dollars are really being spent.
see www.charitywatch.org
3

International medical assistance

American Indian diabetes prevention

Childrens camp scholarship program

Education and prevention programs
Research Program
Cure for Type 1 Diabetes
GRANT TITLE: A Program for the
Cure of Type 1 Diabetes Using a
Generic Drug: Phase II
RESEARCHER: Denise L. Faustman,
MD, PhD., Associate Professor
Harvard Medical School and Director
Immunobiology Laboratory
Massachusetts General Hospital
Charlestown, MA
PURPOSE: After successful comple-
tion of the Phase I human study which
showed that an inexpensive generic
drug (BCG) could actually help the
pancreas regain the ability to produce
small amounts of insulin in long- term
diabetics, Dr. Faustmans research
project has now moved closer to
participant enrollment for the Phase II
clinical trial. The current focus of this
study is to dene subgroups among
long-term diabetics to determine any
differences in response to treat-
ment according to length of illness.
Currently Dr. Faustman is also looking
at how rates of C-peptide decay
and biological variation in C-peptide
secretion might differ in individual par-
ticipants, as well as in the subgroups
of participants who had the same age
of diabetes onset. In the meantime,
follow-up studies of participants
from the successful Phase I trial who
received BCG vaccinations are being
conducted to identify the drug dose
and schedule that will put advanced
Type 1 diabetes into remission.
GRANT TITLE: Role of Bile Acids in
Diabetes Remission after Bariatric
Surgery
RESEARCHER: Blandine Laferrere, MD
Principal Investigator
St. Lukes-Roosevelt Hospital Center
New York, NY
PURPOSE: Bariatric surgery often
results in remission of type 2 diabetes
(T2DM). While weight loss is mainly
responsible for the improved glucose
metabolism, other mechanisms have
been implicated after gastric surgery,
as glucose levels improve rapidly, prior
to any signicant weight loss. In this
proposal, Dr. Laferrere wishes to
characterize new mechanisms
explaining type 2 diabetes remission
after gastric bypass surgery. Speci-
cally, the role of bile acids on the im-
proved glucose and lipid metabolism
and the improved gut peptide release
after gastric bypass surgery will be
tested. Circulating bile acids will be
measured in samples from a cohort
of obese patients with T2DM, before
and after gastric bypass and gastric
banding surgery. Understanding the
effects of gastric bypass surgery on
the action of bile acids will make it
possible to further characterize the
benet of therapies that manipulate
the enterohepatic cycle as treatments
for T2DM.
GRANT TITLE: Stearidonic Acid As
A Potential Nutritional Therapy For
Obesity And Type 2 Diabetes
RESEARCHER: Kevin W. Huggins, PhD
Associate Professor Dept. of Nutrition
Auburn University, AL
PURPOSE: Increased consumption of
n-3 polyunsaturated fatty acids (PUFA)
have been shown to have health
benets associated with obesity
and type 2 diabetes. The n-3 PUFA
obtained from cold water sh and
sh oils are the most effective source
for these effects; however, due to
concerns regarding the safety and
sustainability with sh oils, there is
need to identify alternative sources
of n-3 PUFA having similar biological
properties. Stearidonic acid (SDA) is
a botanical n-3 PUFA that may have
similar health benets to sh oils. The
purpose of this research project is
to determine if SDA can be used as
alternative to sh oil in the prevention
of obesity and/or diabetes. The overall
hypothesis of this research is that
SDA will aid in prevention of adiposity,
inammation, and insulin resistance
associated with obesity and diabetes
in a mouse model. The results from
this research project will serve to
provide proof of principle for SDA as
a therapeutic alternative for the treat-
ment of obesity and type 2 diabetes.
Complementary / Nutrition Research
GRANT TITLE: Novel Insights Into the
Role of Vitamin D in Type 2 Diabetes:
Implications for prevention and
treatment
RESEARCHER: Noelle Larson, MD
Assistant Professor of Pediatrics
Fellow in Pediatric Endocrinology
Tripler Army Medical Center, Hawaii
PURPOSE: Although it is known that
vitamin D deciency is associated with
increased risk of developing insulin
resistance and type 2 diabetes, the
2011 Institute of Medicine Report
on reference intakes for calcium and
vitamin D suggested that interventional
data to support the routine use of
vitamin D in the prevention and
treatment of diabetes was lacking.
This highlights the need for research
to increase the understanding of the
possible role of vitamin D in insulin
action. This study is examining the
effect of vitamin D and its metabolites
on insulin sensitivity in adipose tissue
to test whether vitamin D potentiates
insulin action in fat tissue and to learn
whether Vitamin D is metabolized in fat
tissue. This testing will be performed
on human adipose samples obtained
from patients undergoing elective,
planned surgical procedures as well
as adipose tissue from pigs that will
be used in the assay techniques for
the human samples. Results from both
visceral and subcutaneous fat samples
will be compared from both obese and
lean subjects.
4
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


GRANT TITLE: Vanadium and
Cinnamon Derived Compounds as
Therapies For Wound Healing in
Diabetes
RESEARCHER: Janice Zabolotny,
PhD., Instructor in Medicine
Beth Israel Deaconess Medical Center
Boston, MA
PURPOSE: Diabetic Foot Ulceration is
a major complication of diabetes and
the leading cause of non-traumatic
lower extremity amputation in
the U.S. Despite the clinical need
for therapies for chronic diabetic
wounds, there has been very little
basic research aimed at identifying
molecular mechanisms that can be
augmented to overcome wound
healing impairments in diabetes.
Our data show that intracellular
protein tyrosine phosphatases (PTPs),
negative regulators of growth factor
action, impede cutaneous wound
healing. Blocking the action of PTP-1B
accelerates healing rate and closure
of cutaneous excisional wounds
in diabetic mice. Vanadium and
cinnamon derived compounds are well
known potent inhibitors of PTP-1B,
which also improve glucose tolerance
in diabetic patients and promote
healing of diverse experimental
wounds in healthy animals. This
study will determine whether these
compounds are effective topical
therapies that can restore cutaneous
wound healing in preclinical models of
chronic diabetic wounds.
GRANT TITLE: Identications of Novel
Botanicals For the Prevention and
Treatment of Type 2 Diabetes
RESEARCHER: Dongmin Liu, PhD.
Associate Professor
VA. Polytechnic Institute & State
University
Blacksburg, VA.
PURPOSE: The goal of this project
is to identify low-cost bioactive
compounds as complementary and
alternative approaches to prevent and
treat type 2 diabetes (T2D). T2D is a
growing public health problem which
is a result of chronic insulin resistance
and loss of functional B-cells (the only
source of insulin in our body). Thus,
search for novel agents that
simultaneously prevent insulin resis-
tance and protect B-cell mass could
be a novel and more effective strategy
to prevent T2D. Dr. Liu discovered
for the rst time that baicalein, a
avonoid compound isolated from a
Chinese medicinal herb, ameliorates
diabetes due to protection of func-
tional B-cell mass, while kaempferol,
which is present in various natural
plants and citrus fruits, might be an
insulin sensitizer in the body. In this
project Dr. Liu will explore whether
the combination of treatment with
baicalein and kaempferol is more
effective in preventing T2D develop-
ment by simultaneously preserving
B-cell mass and improving insulin
sensitivity in obese T2D mice.
GRANT TITLE: Comparison of
Fructose and Table Sugar as Sources
of Caloric Excess in a Drosophila
Model of Type 2 Diabetes
RESEARCHER: Laura Musselman,
PhD. Research Instructor in Medicine
Washington Univ. School of Medicine
St. Louis, MO
PURPOSE: Many of us have heard
of the dangers of high fructose corn
syrup, and of caloric excess. Recently,
science has shifted to place the blame
for increased metabolic disease on
dietary sugar instead of fat (see the
NY Times 60 Minutes, HBO). Some
scientists and dieticians suspect that
fructose is worse for health than other
sugars. Dr. Musselman has developed
a model of insulin resistance that
results from high sucrose feeding,
where all dietary sugar consists
of table sugar. High levels of table
sugar induce Type 2 diabetes-like
phenotypes in the fruit y Drosophila.
She has characterized the genomic,
physiological, and biochemical
responses to insulin resistance in
high sucrose-fed Drosophila. What
effects does fructose have? This study
will compare fructose to sucrose
and glucose to try to understand the
differences, if any, between different
sugar-containing diets.
GRANT TITLE: Effect of Chromium
Picolinate On Diabetic Vascular
Complications
RESEARCHER: Priya Raman, PhD.
Assistant Professor
Northeast Ohio Medical University
Rootstown, OH
PURPOSE: Diabetic patients
are highly prone to vascular
complications, substantially impacting
national health care expenditures.
Despite signicant advances, no cost-
effective alternative remedies are
currently available for management
of diabetic macrovascular disease.
Trivalent chromium (Cr3+) picolinate
(CrP), one of the largest-selling
mineral supplements in the U.S.,
has a benecial role in glycemic
and cardiovascular health. Although
previous studies underscore
a protective role of Cr3+ in
atherosclerosis, therapeutic value
of CrP in diabetic vascular disease
and mechanism(s) underlying its
effect remain unknown. Dr. Ramans
preliminary data demonstrates
that CrP decreases expression
of thrombospondin-1 (TSP- 1), a
protein implicated in initiation of
atherosclerosis. Dr. Raman proposes
to test the central hypothesis that
CrP alleviates diabetic atherosclerotic
complications by reducing TSP-1
expression in the vessel walls and
further uncover novel mechanisms
underlying this effect. The proposed
studies will signicantly impact
our current understanding of CrP,
as a benecial alternative and
nutritional therapy for diabetes and its
complications.
Complementary / Nutrition Research
5
GRANT TITLE: Neuroregulation of
Diabetic Nephropathy
RESEARCHER: Babu J. Padanilam, PhD.
Associate Professor
University of Nebraska Medical Center
Omaha, NE
PURPOSE: Diabetic nephropathy
(DN), is one of the most ominous
complications of diabetes, and is
the leading cause of end-stage renal
disease. Recent reports indicate
that sympathetic hyperactivity is
common in chronic kidney disease
(CKD) and is shown to contribute
to glomerular nephritis and induce
proteinuria both through and beyond
its effect on blood pressure. Several
recent reports indicate that increased
sympathetic activation is an early
event in the pathophysiology of
CKD, rather than a consequence,
and its sustained activity has
adverse clinical consequences.
The objective of this proposal is
to determine if renal denervation
prevents the pathophysiology of
diabetic nephropathy and dene the
mechanisms by which renal nerve
activation instigates inammation
and brogenesis in T2D kidneys.
These proposed studies on the neural
regulation of renal brogenesis are
paradigm-shifting as it has never been
reported and will have the potential
to transform the way we investigate
broproliferative diseases. Elucidation
of neural regulation in DN may provide
a conceptual framework for identifying
novel therapeutic targets.
GRANT TITLE: Role of VGF in Beta
Cell Function, Insulin Secretion, and
Glucose Homeostasis
RESEARCHER: Stephen R.J. Salton,
M.D., PhD
Professor of Neuroscience and
Geriatrics
Mt. Sinai School of Medicine
New York, NY
PURPOSE: Germline ablation of
the Vgf gene results in a lean and
hypermetabolic knockout mouse
that is resistant to diet-, lesion- and
genetically-induced obesity and
diabetes. Modulation of VGF levels or
VGF signaling may therefore represent
an alternative means to regulate
circulating glucose levels and insulin
sensitivity. Recent studies from the
Newgard lab have demonstrated
that the VGF-derived peptide TLQP21
enhances insulin secretion, improves
glucose homeostasis, and preserves
beta cell mass, through a mechanism
that is similar to but distinct from GLP-
1R agonists. Utilizing previous Dia-
betes Action funding, Dr. Salton has
generated VGF mouse models that (1)
express full length human VGF(1-615),
(2)express truncated VGF(1-524)
that lacks the TLQP21 peptide, or (3)
have loxp recombination sites anking
the mouse VGF coding sequence.
To further investigate mechanisms
by which VGF regulates glucose
balance, Dr. Salton will generate and
characterize beta-cell conditional VGF
knockout mice, and lines expressing
full length and truncated human VGF.
Gene Research
GRANT TITLE: Myeloid-Derived
Suppressor Cells for Tolerance to Islet
Transplants
RESEARCHER: P.I., Luca Inverardi, MD,
PhD, Research Professor of Medicine,
Microbiology and Immunology
Co-P.I., Paola Serani, PhD., Asst. Re-
search Professor, Dept. of Microbiology
and Immunology
Alessia Zoso, PhD., Diabetes Research
Institute Foundation
Hollywood, Florida
PURPOSE: Survival of transplanted
insulin producing islet cells requires
life-long immunosuppressive drugs,
which cause a number of undesirable
side effects including damage to the
islets themselves. They also shut
down the entire immune system,
leaving the patient susceptible to
viruses and infections. The critical
need that this project addresses
is to obtain a means of inducing
transplant tolerance- thus changing
islet transplantation from a procedure
with serious side effects to a safe
one. Myeloid-Derived Suppressor
Cells (MDSCs) naturally accumulate
in certain areas of the body. Cancer
researchers are familiar with the
negative effect of MDSCs on malig-
nant tumors but this study attempts
to put MDSCs to work in our favor
by using them to interfere with the
immune systems ability to attack
the insulin-producing islet cells that
we transplant to reverse diabetes.
Beta Cell Research Kidney Research
GRANT TITLE: Lifestyle Intervention
For Diabetes
RESEARCHER: Adam Bernstein, MD
Director of Research, Wellness Institute
Cleveland Clinic
Cleveland, Ohio
PURPOSE: Although targeting low-
income women for health care
screening and interventions has been
a priority of the US Centers for Disease
Control and Prevention for the past 15
years, little is known on how to adapt
and deliver evidence-based lifestyle
interventions for chronic disease to
t the needs of low-income, urban
populations. Dr. Bernstein proposes a
pilot study of a lifestyle modication
program for overweight or obese
African-American women with
diabetes. As recommended by the
ADA, the program emphasizes diet,
exercise, and cognitive behavioral
therapy. However, based on focus
groups performed with African-
American women in the low-income
community of East Cleveland, Dr.
Bernstin proposes the incorporation of
mind-body practices that address more
inner and spiritual aspects of mental
health to allow participants to maintain
the recommended lifestyle changes in
a sustainable manner. If successful, the
proposed research has the potential
to signicantly affect the health and
quality of life of a large percentage of
the population.
Education
6
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


GRANT TITLE: Multidrug Resistance
Protein-1 as an Essential Regulator of
Vascular Inammation and Diabetic
Restenosis
RESEARCHER: Manikandan
Panchatcharam, PhD.
Assistant Professor
Department of Cellular Biology and
Anatomy
LSU Health Sciences Center,
Shreveport, LA
PURPOSE: Approximately 180 million
people worldwide have diabetes
and this gure is expected to grow
to 366 million in 2025, according to
the Centers for Disease Control and
Prevention. Diabetes is a chronic
disease in which a person has high
blood sugar, which leads to the clas-
sical symptoms of polyuria (frequent
urination), polydipsia (increased thirst)
and polyphagia (Increased hunger).
Left unmanaged, diabetes can bring
on complications such as heart
disease, problematic vision, kidney
disease, nerve damage and loss of
limbs. Drugs used to treat uptake of
sugar in cells are not effective due
to the action of multidrug resistance
proteins, which are elevated during
diabetic condition. The major problem
addressed here is to study the role
of multidrug resistance protein-1 in
normal and diabetic condition, which
would lead to a new window for the
therapeutic treatment by regulating
multidrug resistance protein-1 levels
in the diabetic patients.
GRANT TITLE: Coaching for Control:
A Pilot Study of a Medical Student
Intervention to Promote Diabetes
Self-Care in High Risk Settings
RESEARCHER: Mercedes Carnethon,
PhD, Assoc. Professor
Associate Chair for Mentoring &
Faculty Development
Northwestern University
Chicago, IL
PURPOSE: Diabetes poses a substan-
tial burden to racial/ethnic minorities
and in populations with limited access
to healthcare. However, there is a
shortage of healthcare providers
available to help patients adopt the
lifestyle changes required for diabetes
control. The goal of this study is to
evaluate the feasibility and effective-
ness of a diabetes self-care interven-
tion delivered by medical students
to patients with poorly controlled
diabetes. Training medical students to
use proven communication techniques
to help patients identify and overcome
barriers to adopting lifestyle changes
in diabetes is a novel but plausible
strategy. Dr. Carnethon anticipates
that ndings from this pilot study will
be used to develop a larger study
to denitively test the programs
effectiveness. A long-term benet of
this program is that future healthcare
providers are practicing the skills
needed to promote positive lifestyle
changes and provide care for chronic
conditions in diverse communities.
GRANT TITLE: The Diabetes Center
Summit: Operations, Management
and Quality Imperatives
RESEARCHER: Les Jebson, M.H.A.
Administrator, The Diabetes Center of
Excellence
Univ. of Florida Academic Health
System
Gainesville, FL
PURPOSE: In 2009, approximately
1,406,000 adults in the state of
Florida had been diagnosed with
diabetes. In 2009 approximately 87%
of all adults in Florida were overweight
or obese and 41.6% were physically
inactive. This summit will focus on
how to better manage the diabetes
population in Florida, with the intent
being that its success and design can
be used for other state level or
regional diabetes educational events
in other geographic locations through-
out the country. This conference is
unique by being designed for Admin-
istrators, Managers, and Research
Coordinators of Diabetes facilities
throughout the region and will be
free of charge for attendees without
any commercial/industry funding. In
order to better manage the exploding
population of patients with diabetes,
it is critical that innovative ways of in-
creasing coordination among diabetes
care providers be developed in this
Symposium.
GRANT TITLE: The Development
of an Evidence-Based Smartphone
Application for Diabetes
Self-Management
RESEARCHER: Ronald Tamler, MD
Director, The Mount Sinai Diabetes
Center
Mt. Sinai School of Medicine
New York, NY
PURPOSE: The goal of this project
is to build a Smartphone application
(app) based on clinical evidence
and established behavioral science
that makes it easier for people with
diabetes to self-manage this chronic
disease. The study will use focus
groups, the development team and a
3 month pilot study to develop the
efcacy and usability of the Smart-
phone app. Dr. Tamler hopes to make
this chronic disease management tool
widely available on both the website
and app stores so that thousands of
people with diabetes will be able to
download the app and self -manage
their disease by monitoring their
nutritional habits, life style choices
and medication adherence, among
other features which will empower
patients with diabetes.
Education Vascular Research
7
GRANT TITLE: Chromatin Protein
Complexes and Regulation of Cardiac
Hypertrophy
RESEARCHER: Susan Marsh, PhD.,
Assistant Professor
Washington State University
Spokane, WA
PURPOSE: The heart undergoes
changes in shape and strength
(hypertrophy) in response to hyperten-
sion, diabetes, and exercise training,
although the remodeling caused by
these interventions results in differ-
ences in the shape, size, and function
of the hearts muscle cells. Hyperten-
sion causes hypertrophy through
changes in protein interactions that
regulate the winding and unwinding
of DNA, which, in turn, affects which
genes are copied; this ultimately
determines the changes that occur
in the muscle cells of the heart. Our
preliminary experiments indicate that
these events also occur in exercise-
trained and diabetic hearts which is
somewhat unexpected as exercise-
trained hearts are stronger and more
efcient than hypertensive and/or
diabetic hearts. The studies in the pro-
posal will investigate whether these
changes are essential for remodeling
of the hearts muscle cells.
GRANT TITLE: Exploiting A Novel
ATP-Regulated Molecular Switch To
Selectively Boost Akt2, But Not Akt1
Signaling In Diabetic Cardiomyopathy
RESEARCHER: Tung Chan, PhD.,
Assistant Professor of Medicine
Thomas Jefferson University
Philadelphia, PA.
PURPOSE: Patients suffering from dia-
betes, in particular African-Americans,
are at increased risk of developing
heart disease, even without high blood
pressure. Heart disease remains the
leading cause of death in the US and
despite therapeutic improvements,
outcomes in chronic heart failure
remain poor with a 5-year survival
only around 50%. While moderately
effective, current treatment options
for diabetic heart failure are limited. In
this application, Dr. Chan will help to
develop a novel effective treatment for
this condition by restoring the function
of a critical intracellular effector of
insulin action (Akt2) in cardiomyocytes.
A second focus of this study is the
development of new assays that can
be used in living human heart tissues
or fat tissues to study differences
in response from heart failure and
diabetes patients.
GRANT TITLE: Reversal of Diabetic
Neuropathy by a Ketogenic Diet
RESEARCHER: Charles Mobbs, PhD.
Professor, Neuroscience,
Endocrinology, and Geriatrics
Mt. Sinai School of Medicine
New York, NY
PURPOSE: Dr. Mobbs recently
reported that a ketogenic diet
reverses diabetic nephropathy in
mouse models of both Type 1 and
Type 2 diabetes and that ketones are
highly protective of neurons in an in
vitro model of diabetic neuropathy.
Furthermore, the ketogenic diet is
clinically safe and effective in treating
epilepsy in humans and diabetic
neuropathy appears to be at least
partially reversible under optimum
conditions. Thus Dr. Mobbs hypoth-
esizes that the ketogenic diet will
also at least partially reverse diabetic
neuropathy by reducing glucose
metabolism more effectively than
simply reducing blood glucose, as
analyses of bistable metabolic states
suggest that even temporary but
substantial reduction in glucose
metabolism may reset the meta-
bolic state and produce protective
effects that persist after resumption
of a normal diet. Thus, the goal of this
study is to assess if the ketogenic diet
will reverse diabetic neuropathy in a
mouse model of type 2 diabetes and if
these protective effects persist even
after a return to a normal diet.
GRANT TITLE: The Mechanism
Approach of the Therapy For Diabetic
Neuropathic Pain
RESEARCHER: Yan Ping Zhang, PhD.,
Assistant Scientist
University of Miami
Miami, Florida
PURPOSE: Diabetic Neuropathy is a
nerve disorder caused by high blood
sugar. About 60-70% of people with
diabetes have mild to severe forms of
diabetic neuropathy. Painful diabetic
neuropathy (PDN) can have devastat-
ing effects on a patients health and
overall quality of life. High blood sugar
causes metabolic dysfunction trigger-
ing nerve damage in diabetes. Cells
and tissues damaged by high blood
sugar in turn stimulate the natural
immune defense system to produce
free radicals (highly reactive oxygen
molecules that damage tissues) and
toll-like receptor 4 (TLR4) is critically
important in regulating these respons-
es. In diabetes, Dr. Zhang hypothesiz-
es that TLR4 activation in the spinal
cord plays a key role in perpetuating
neuronal injury and the symptoms of
PDN. The proposed research will apply
TLR4 antagonist to inhibit potentially
harmful natural immune responses,
and protect from PDN.
Heart Disease Neuropathy
8
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


Beneficial Effects of Cinnamon on Diabetes and Alzheimers Disease
Dr. Richard Anderson described his many years of research, including studies
that were supported by Diabetes Action, which showed the health benets of
a water-soluble extract of cinnamon. This extract has not only been shown to
improve insulin resistance in women with polycystic ovary syndrome, improve
blood glucose, blood pressure and cholesterol levels in people with metabolic
syndrome, but was also shown to prevent the growth of blood vessels necessary
for the spread of cancer. In addition, Dr. Anderson demonstrated how cinnamon
was able to break up the Alzheimers laments from a human brain.
Short Chain Fatty Acids in Coconut Oil and Ketogenic Diets
Food for Thought
Dr. Beverly Teter provided information on the benets of a ketogenic diet, which
is high in good fats such as organic butter, whole fat dairy (which an NIH funded
Harvard study had previously shown to lessen the risk of type 2 diabetes by
60%), coconut, and avocado oil. Dr. Teter stressed the need for fat to nourish the
brain and discussed her contacts with Dr. Mary Newport, who treated her
husbands Alzheimers with coconut oil. Thus, it may be time to rethink the
popular advice to avoid all saturated fats.
The Importance of Vitamin D in Diabetes: The state of the Science
and the Practice
Dr. Ryan Bradley discussed the results of his own research study that tested
three different forms of Vitamin D, and also described conicting results of
numerous studies on the benets of vitamin D for diabetes. Numerous studies
have shown that higher levels of vitamin D are associated with a decreased risk
of developing type 2 diabetes. For type 1 diabetes, although some studies did
not show an improvement in C Peptide levels after taking supplemental D, other
studies that used higher doses of vitamin D did show signicant improvement,
so the results may be dose dependent. The most illuminating statistic was
that children with low vitamin D levels have a 200% increased risk of
developing type 1.
Education Program
Diabetes University
Diabetes Actions annual Diabetes University provides updated
information on diabetes treatment and focuses on alternative
therapies which are an area of interest to more and more people
seeking non-traditional ways to improve their health. Our 2013
program featured the following presentations:
Please visit www.diabetesaction.org to view past and current Diabetes University programs.
Dr. Teter explained why
the brain needs fat and
how coconut oil is a
healthy saturated fat.
9
American Indian Diabetes Prevention Program
Our ongoing support of the American Indian Diabetes Prevention Program is helping to ght the
epidemic of type 2 diabetes on the Cheyenne River Reservation in South Dakota by promoting
a return to traditional foods, exercise programs, and public health education.
In addition to the efforts of a diabetes educator who has provided nutrition
programs for both children and their families, our funding in 2013
supported the rst ever Teen Internship program focused on youth
wellness and the two acre Winyan Toka Win (Leading Lady) Garden.
During this special summer program, the teens not only learned
the basics of gardening, processing, and canning, but they also
received CPR and food handler certication, attended special
training sessions in nancial literacy, suicide prevention, drug and
alcohol prevention, and basic nutrition and diabetes prevention.
One of the biggest hurdles to overcome on most reservations is
the reliance on the Federal Food Program that provides unhealthy
foods such as processed meats, which have been shown to
contribute to diabetes. Replacing packaged food with food
harvested from the land will help these teens reduce their
risk of diabetes.
This highly successful program helped the teens form new healthy habits
while encouraging their family and friends to live a more healthy life.
10
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


Diabetes Action Team
Congratulations to the 216 Diabetes Action Team members for
raising over $168,000 for diabetes research in 2013! Each team
member had their own inspiring story and reason for joining the
team, but everyone came together with the common goal of
raising money to fund vital research. We are so proud of all our
team members for both their athletic accomplishments and their
amazing commitment to the cause of conquering diabetes.
BANK OF
AMERICA
CHICAGO
MARATHON
Cristine Ale
Nicholas Allen
Jeanette
Anderson
Chris Anderson
Venkat Arcot
Erika Barragan
Erico Barrera
Ryan Bauer
Kevin Beyer
Tracey Bustin
Brock Buttrick
Robert Caton
Joshua Crowley
Suzanne Dailey
Benjamin Deines
Arra Derderian
Tom Dow
Mel Eason
Beiker Espinoza
James Fisher
Amanda Funk
Celeste Galizia
Tim Geraghty
Kevin Greene
John Guanzon
Shelli Hancock
Jessica
Harpenau
Lindsay
Hattendorf
Jason Heckman
Kaylyn Howley
Alvaro Hoyos
Jonathan James
Venkata Jayanti
David Johnson
Jill Jones
Julie Karwowicz
Robert Kern
Monica Korell
John Kovas
Jennifer Laun
Kellie Leinung
Bobbi Long
Vincent Luna
Jody Malone
Jeffery Martin
Robert Meyer
Maren Mineo
Rica Misra
Troy Moffett
Santa Montiel
Antonio
Montiel Jr.
Eddie Mora
Bryan Morin
Colin Morlock
Patrick Morrison
Christine
Morrison
David Mussatt
Kim Nelson
Paul Nette
Patrick
Newcomer
Han Ngo
Vanatus
Nwaigwe
Michael Oakes
Vipul Patel
Athena Perez
Andrew Perez
David Phillips
Mindy Poleski
Matt Polifko
Matt Pook
Margaret Portelli
Arianne
Rodriguez
Renee Rossi
Anna Ruspa
Nikki Rybarczyk
Lea Sawicki
Kody Scherbarth
Kimberly Schmitt
Ashley Schock
Nakima Sepulveda
Summer Smith
Jonathan Starke
Shannon Sullivan
Barb Tatham
Joseph Tess
Billi Tierney
Erik Toman
Rakesh Reddy
Veligati
Lawton Warzala
Jesse Wickizer
Bruce Willcox
Valerie Yaw
Jeffrey
Zonderman
MARINE CORPS
MARATHON
Daniel Adame
Roberto Anguizola
Nicholas Beeson
Jerry Bennett
Neil Boulton
Lynn Bowen
Kevin Boyce
Marshall Braun
Monique Canale
Omar Canty
Jasper Caparas
David Cleveland
Laura Cohen
Brian Coughlan
Cindy Coxie
Neelima
Dandamudi
Angela Diorio
Deborah Dorber
Courtney
Duckworth
Tami Estep
Seth Ewing
Ken Fagut
Barb Flahive
Matthew Garcia
Luis Garcia
Dan Gay
Jerome Geisler
John Hesser
Nancy Highburger
Suzanne House
Jimmy Huang
Zach Hutcheson
Christine
Hutcheson
Jan Irvine
Gregory Jones
Jeremy
Karbowski
Vandana Kumari
Elizabeth Lazdins
Stuart Levinsky
Gisele Loto-Rojas
Lynn Mattucci
Carrie McKinney
Benjamin
McNaughton
Dawn
McNaughton
Dawn Meyers
Kasey Mitchell
Dena Mizrahi
John Morrison
Mallory Myers
Dawn Nelson
Virginia Parker
Bonilyn Parker
Janet Petersen
Brian Phelps
Christopher
Piskun
Bhaviksha
Ranchod
Angela Reineck
Jalil Rodriguez
Perez
Augusto Rojas Jr.
Bob Romero
Claudia Saavedra
Claudia Santos
Jenica Scott
Kelly Snavely
Michael Spencer
John Spillane
Victoria Spratt
Matthew
Stiegemeyer
Marilyn Swann
Xochitl VanderPlas
Melissa Voight
Karen Walden
Lisa Whalen
Thomas Willauer
Christopher
Willauer
Ever Zavala
NYC HALF
MARATHON
Kaja Gjessing-
Newman
Damian Romero
Deana Welsch
ROCK N ROLL
USA
DMeryl Grenadier
Danielle Gurkin
Peggy Ledell
Tanya Pardo
Chris Roberts
VIRTUAL
DIABETES
ACTION TEAM
Dana Canzano
Katherine Krause
Ronald Lawrence
2013 Team Members
SPECIAL THANKS TO
OUR TOP FUNDRAISERS
Jerry Bennett $5,768
Augusto Rojas Jr. $4,034
Stuart Levinsky $2,808
Kaja Gjessing-
Newman $2,482
Shannon Sullivan $2,166
Janet Petersen $2,126
Danielle Gurkin $1,695
Gregory Jones $1,627
Lynn Bowen $1,575
Kellie Leinung $1,532
11
In 2013 Diabetes Action provided over 1.6 million dollars of medical supplies to aid the victims
of natural disasters in both Haiti and the Philippines.
In Haiti, life is still a struggle for millions of people trying to recover from the devastating
earthquake of 2010 and the following cholera epidemic that has strained the resources of all
medical facilities. Our medical supplies were distributed to hospitals at St. Marc, Cabara, and
Arachaia plus various medical clinics in outlying villages such as LaDigue.
After a massive typhoon destroyed many rural health clinics in the Philippines, Diabetes Action
sent additional medical supplies to help provide medical care to the more than 14 million people
affected by this devastating typhoon. Medical Clinics run by Children International in Quezon
City, Manila, and Legaspi City were grateful to receive this much-needed medical assistance.
Relief Efforts
2013 Childrens Summer Camps
One of our most gratifying programs is the annual support of summer camps for children with
diabetes. At these camps, children with diabetes have a place to feel normal with other kids
living with diabetes in a safe environment. Camp combines fun and adventure along with
education on how to manage a healthy life with diabetes. We love to read the stories from
children who write each year to thank us for making it possible to have this special
experience, but the letters from parents are also heartwarming. A mom of a camper recently
wrote, Danielle has not stopped talking about camp and the friends she made who are just
like her! She was so proud of herself for coming home with the ability to give herself some of
her injectionsa big step forward for her.
Summer Camps
Camp Seale Harris, AL
Camp Kushtaka, AK

Camp Aldersgate, AR

U of Arizona Foundation, AZ

Camp
Conrad Chinook, CA Camp Sweet Pea, CO
Rainbow Club, CT
Camp Possibilities, DE


College of Health and
Nursing Sciences, DE

Florida Diabetes Camp, FL

Camp Kudzu, GA

YMCA Honalulu, HI

Camp Hodia, ID

Camp Granada, IL
Triangle D Camp for Children with Diabetes, IL

Diabetes Youth Foundation, IN

Hertko
Hollow Childrens Diabetes Camp, IA

Camp Discovery, KS

Camp Hendon, KY

Camp Victory, LA

Clara
Barton Camp, MA

Lions Camp Merrick, MD

Carys Diabetes Kids, ME

Camp Midicha, MI

Camp Needlepoint,
MN

Camp Daypoint, MN

Camp Hickory Hill, MO

Youth Retreat, MT

Twin Lakes Diabetes Camp, MS

Camp Carolina Trails, NC

Camp Sioux, ND

Nevada Diabetes Association, NV

Floyd Rodgers Camp, NE

Camp
Carefree, NH

Zebra Crossing, NH

Camp Nejeda, NJ

Kamp 4 Kids, NM

Circle of Life Camp, NY

Camp
HoMita Koda, OH

Camp Korelitz, OH

Camp Endres, OK

Chris Dudley Basketball Camp, OR

Camp Setebaid,
PA

CEBNAD Diabetes Camp, PR

Camp Surere, RI

Camp Adam Fisher, SC

Camp Gilbert, SD

Tennessee
Camp for Diabetic Children, TN

Texas Lions Camp, TX

Utada Camp, UT

AYUDA, VA

Camp Holiday Trails,
VA

Camp Sealth, WA

Wisconsin Lions Camp, WI

Camp Kno-Koma, WV

Camp Hope, WY
12
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


Financials/Misc.
Board
BOARD CHAIR:
Patricia A Faulkner
TREASURER/SECRETARY:
Anne Lafferty
DIRECTORS:
Rachel Goldfarb
Joan Kaiser
Donald T. Krizek, Ph.D.
Jan Taylor
Principal
Staff Members:
PRESIDENT:
Pat DeVoe, RN, BSN
EXECUTIVE DIRECTOR:
Dorothy Harriot, LCSW-C
Diabetes Action Research
and Education Foundation Inc.
BALANCE SHEET
December 31, 2013
ASSETS
Current Assets
Cash - Checking $40,315
Cash Money Market $158,749
TOTAL ASSETS $199,064
PUBLIC SUPPORT AND REVENUE
Contributions $586,864
In-Kind Contributions $1,682,512
Legacies, Bequests $24,453
Interest Income $94
Other Income $335
Special Events $159,610
TOTAL PUBLIC SUPPORT AND REVENUE $2,453,868
EXPENSES
Public Education $316,400
Biomedical Research $257,575
Summer Camps $21,450
In-Kind Medical Supplies $1,682,512
Contract Services $110,000
TOTAL PROGRAM SERVICES $2,387,937
General and Administrative $62,062
Fundraising $13,173
TOTAL EXPENSES $2,463,172
Decrease in Unrestricted Net Assets ($9,304)
Net Assets - Beginning of Year $188,405
Net Assets - End of Year $179,101
LIABILITIES AND NET ASSETS
Credit Card Payable $ 1,496
Payroll Taxes Payable $7,717
Accrued Expenses $10,750
Total Liabilities $19,963
Net Assets - Unrestricted $179,101
Total Liabilities and Net Assets $ 199,064
Expenses
Program Services: 97%
(Research, Education,
Summer Camps,
Medical Supplies)
Fundraising: .5%
Administrative: 2.5%
Complete nancial statement audited by Eric Bolin, CPA, P.C. available on request
13
Aaron Hilden
Alfreda Carpenter
Allan Bley
Alonzo Lonnie Brewster
Angela Addonizio
Anna Betsy Whitmer
Arnold Schwartz
Beatrice Alvarado
Benton B. Perry
Bernard Jay Faver
Betty Guy
Betty J. Birchett
Bill Plourde
Billye Jean Allen
Bryant Lee Jewell
Byron Kirk McAllister
Cara Wright
Carl Strein
Caroline Obadiah
Carrie Weigel
Charles Sobol
Charlotte Shrader
Christopher Tavlarides
Christopher Wilson
Colette F. Fennessy
Colleen Nielson
Darrell Earl Moffett
David Sasicario
David Schiff
Diana Nevers Mooney
Diane Dobozynski
Donald L. Willett
Donald W. Bourne
Donna Fish Haynes
Donna Salmon
Doris V. Miller
Dorothy Augugliaro (Gorski)
Dr. William Marek
Duncan McDougall
Edith Grossman
Edmond Mike Petrosky
El-Said Shalaby
Eleonora Reszka Doktorczyk
Ellen Ruth Redditt
Erin Marcus
Erma Biederman
Ethel Erickson
Evelyn Gehringer
Frances A. Matthews
Francis Dall
Francis Paciga
Gail Lefton
Gene Erba
George Casha
George Rakoci
Gerald O. Kankaala
Geraldine Opal Leverenz
Gil McWilliams, Sr.
Gilbert Weller
Glenna Glauber
Gloria Morgan Rawls
Guy Pinter
Guy William Hart
Gwendolyn Maxine Heasty
Harry Pirlot
Helen Bucki
Helen Collura
Henry Roman
Herbert Wilkins
Irene I. Swienczyk
Izabella Dolata
James Brennan
James FIeld
James Galarowicz
James L. Dambacher
James M. Sheppard
James N. Miller
James Wallace
Jason Jangsik Lee
Jean Gengler
Jeff Westby
Jeketha Belinger
Jim Barbre
Jimmy Ciarcio
Jo-Ann Pitt
Joan Pauline Jackson
Joanne Adams
John Ferrando
John Giddens
John Lee
John V. Tzouras
Jon Hayes
Judith Chase
Judith Lamar
Julius & Ruth Meiste
Kathy Post
Kevin Dooley
Laurie Clark
Lin Kou Tsan
Lois Raphael
Lorraine Ernst
Lorraine Lee
Louise Pecikonis Talia
Lynn Marie Rivers
Lynn Wilson
Mabel K. Unsinn
Madeline Jewell
Margaret Lisa Beckmann
Margarete Sylvia Rock
Mark Nussmeyer
Martin Shaw
Mary Anne Anderson
Mary Brandau
Mary Westfall
Michael Del Sordo
Michael P. Allen
Miguel A. Colon
Mina Kupferman
Mr. Carrol Craig
Mrs. Debra L. Spector
Mrs. William (Jane) Chase
Nancy Lawrence
Necip Nej Simer
Neil Fero
Ollie Demchuk
Paul Kenneth Bunce
Acknowledgements
Diabetes Action is deeply grateful to the following donations made in memory or in honor of a loved one.
2013 Memorial Contribution
Gifts made in loving memory of:
Adam Bavifard
Albert Ng, Cheow
Leng
Andy Andrews
Anna Maria Gapuz
Shirley Slotnik
Brian Phelps
Carol Reese
Charles J. Thomas
Christie Trudo
Christopher and
Annette Cook
Cindy Kelso
Claire Schneider
David Marino and
Elizabeth Kim
David W. Williams
David Winmill
Desiree McNamee
Devin Godfrey
Diane Dobozynski
Dolores (June)
Krahn
Donna Mitchell
Donna Llevitz
Dr. Vanatus
Nwagwe
Earle & Gwyn Hicks
Elaine Simpson
Elizabeth Lazdins
Ellen Seidenfrau
Evan Haskell
Gary Hidalgo
Greg & Megan
Sheldon
Grifn Criste
Heidi Kobb
Infor Healthcare
Jack Lane
James Garelick
James McLinn
James Newell
Janice Sharma
Jeff Smith
Jill Leff
Krissy Fergus
La Vonne Boone
Lainee and Roye
Ginsberg
Lee Peltzman
Lisa & Bob Hephner
Mark C. Denchy
Mary & Bill Raws
Mary Beth Fitts and
Greg Kopsch
Melanie Hargrove
Middleswart Family
Mr. and Mrs. Louis
J. Stempy
Mrs. Mary Margaret
McGuire
Nabeel Zafar
Paige and Keith Orgel
Paul Scranton
Paula Leeds
Rachel Moser
Raechel Adams
Reeves Family
Richard Holcombe
Richard Price
Robby Minovitz
Ronald Ripps
Rosanne and James
Testa
Rosemarie and
Alfred Tella
Sean H. Doyle
Shirley Smith
Sue and Joe Butler
Sue McIntosh
Sydney Levin
Thomas Johnson
2013 Honorary Contributions
Gifts were made in honor and celebration of:
Sindhu Abraham
Cristine Ale
Joy Barbre
John and Margaret
Brooke
Robert and Cynthia
Bunker
Joseph Campbell
Ian Carnathan
Tom and Dee Crosby
Thomas Crosby
Brad Defenbaugh
Thomas Egan Digges
Trust
Jill and Dan Dion
American Dream Builders
Weissman Family
Foundation
Fiber-Line Inc.
Mr. and Mrs. Robert C.
Forchheimer
Equifax Foundation
Poker Gives Foundation
Varina Lions Club
Megan Graber and Greg
Sheldon
Patricia Graham
Stephanie Hansen
Kenneth Harrop
Kensington Capital
Holdings
Solomon Kornbluh
Karl Laun
Christopher Maffris
Milton and Tamar Maltz
Family Foundation
Carl and Julie Manello
Samuel Marcus
Jeffery Martin
Tom McKeithen
Vincent Meiste
Rica Misra
Troy Moffett
Anand Nair
William Napiecinski
Wilson Ng
John Nolan
Tom Olsen
Jennifer Paul
Janet Petersen
Anthony Petruzzi
Mary A. Reyburn
Renee Rossi
Dennis Samuel
Susan Smith
Susan Staneld
Abby Steele
Barbara Lee Stifer
Marilyn Swann
Pierre and Kay Gaston
Ttee
Yvonne and John Vasicek
Mark Viehmeyer
Katherine Viveiros
John Webb
Thank you to our most
generous donors (partial listing)
A special thanks to the many Federal
Employees and Military Personnel that
donated through the Combined Federal
Campaign and to the participants of
state and corporate campaigns across
the country.
Paul Crowe
Paula L. Baumgardner
Pauline Wright
Phyllis OBanion
Priscilla Stalker
Raymond M. Stead
Richard K. Insogna
Richard Singleton
Richard Waggoner
Robert B. Cloud
Robert Bruce Haldeman
Robert Cartwright
Robert J. Everheart
Robert Kress
Robert L. Kwiatkowski
Rosario Gomez Cruz
Rose Soultanian
Ruby Retcher
Russell Kline
Russell L. Evinrude
Sadie Robinson
Sam Misuraca
Sandra B. Fitzgerald
Sandra LaParl
Sandra Schwartz
Saul Cayne
Simon Edwin Alleman
Sonia Leopold
Sonia Rosicki
Thomas Morrison
Timothy Hudson
Tom Fisher
Tony Vann
Trish Cleary
Virginia I. Asikainen
Vivian Dunn
Vondelle Graef Martin
Warren Baylet
William Bill Moffett
William Joynt
William McIntyre
William P. Peterson
Yvonne Myers
2
0
1
3

a
n
n
u
a
l

r
e
p
o
r
t

a
n
d

o
v
e
r
v
i
e
w


Diabetes Action 6701 Democracy Blvd., Suite 300 Bethesda, MD 20817 PHONE 202.333.4520 www.diabetesaction.org
How You Can Help
Your support ensures the advancement of Diabetes Actions
mission to prevent and cure diabetes.
Donate Online
Make a general donation or pay tribute to a loved one.
Matching Grants
Many businesses sponsor matching grant programs. Ask your
employer if they offer a matching grant program to multiply the
value of your contribution.
Workplace or CFC Campaign
Look for Diabetes Action Research and Education Foundation in
your campaign directory. Even a small contribution per paycheck
will make a difference.
Planned Giving
Including Diabetes Action as a beneciary in your will or life
insurance policy is a generous way to leave a legacy of hope.
twitter.com/Diabetes_Action
facebook.com/DiabetesAction